The promise of CAR macrophages
T cells have long held the title of the ideal immune cells for CAR therapy, but recent discoveries are opening new possibilities for other immune cells.
cell therapy
Engineered T cells turn cancer’s strength against itself
Researchers mix gene editing with the principles of martial arts to boost T cell therapies.
Umbilical cord blood: a lifeline for pediatric diseases
Doctors are recording a wave of wins using cord blood to heal sick children. The clinical evidence suggests that more wins may come.
Making CAR T cell therapy more accessible
Allogeneic T cells may serve as universal, ready-to-use therapeutic agents for large scale clinical applications.
Switching on safer CAR T cell therapy
By activating CAR T cells only in the presence of an antibody switch, Travis Young and his team hope to make this cancer treatment safer and more effective.
Explained: How do scientists make cell and gene therapy products?
The early steps of viral vector production influence cell and gene therapy success.
Giving the Immune System a Hand
The immune system comprises a treasure trove of cell types with the potential to destroy cancer cells.
The Promise of CAR NK Cell Therapy
Learn how scientists leverage the power of natural killer cells to fight cancer.
Expanding Opportunities for Single Cell RNA-sequencing
LIVE JUNE 23rd, 2022 at 2:30 PM
Uncover genomic and epigenomic variations within a group of cells using single cell sequencing.
Uncover genomic and epigenomic variations within a group of cells using single cell sequencing.
Penetrating Solid Tumors with CAR Immune Cells
LIVE October 13th, 2021 at 10:30 AM ET
Experts will discuss advances that bring CAR therapy for solid tumors one step closer to reality.
Experts will discuss advances that bring CAR therapy for solid tumors one step closer to reality.
